Daudi Electroporation Kit-Burkitt's Lymphoma Cells
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 4 ml(Cat-656530) | Inquiry | Add to cart | |
| 30 ml(Cat-658628) | Inquiry | Add to cart |
Product Information
Modes of administration
Electroporation Efficiency:Electroporation kit provides 70-85% delivery efficiency of siRNA. Electroporation efficiency was determined by qRT-PCR.
Description
The Burkitt's lymphoma patient's lymphoma cells were used to create the Daudi cell line, a human B-lymphoblastoid cell line. It has been named by David Burkitt, a doctor originally identified the lymphoma. Numerous B cell biology topics, including as antigen presentation and processing, immunoglobulin synthesis, and antibody-mediated cytotoxicity, have been intensively studied using the Daudi cell line as a model system. These cells have also been utilized to look into how prospective cancer treatments for lymphomas and other tumors work. The Daudi cell line can be cultivated under typical cell culture conditions and is freely accessible from numerous cell banks. Numerous studies looking at the genetic and molecular causes of Burkitt's lymphoma and other B cell lymphomas have made use of it.
